language-icon Old Web
English
Sign In

More Proof that PrEP Works

2021 
The EPIC-NSW study of the effectiveness of once-daily tenofovir/emtricitabine for preexposure prophylaxis (PrEP) initially enrolled 3700 predominantly
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []